There is significant doubt, like why all their revenues for >year are held up in receivables with payables blowing out to suppliers.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025